These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 11562312)

  • 21. Incorporation of thio-pseudoisocytosine into triplex-forming peptide nucleic acids for enhanced recognition of RNA duplexes.
    Devi G; Yuan Z; Lu Y; Zhao Y; Chen G
    Nucleic Acids Res; 2014 Apr; 42(6):4008-18. PubMed ID: 24423869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and purification of peptide nucleic acids.
    Braasch DA; Nulf CJ; Corey DR
    Curr Protoc Nucleic Acid Chem; 2002 Aug; Chapter 4():Unit 4.11. PubMed ID: 18428893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into peptide nucleic acid (PNA) structural features: the crystal structure of a D-lysine-based chiral PNA-DNA duplex.
    Menchise V; De Simone G; Tedeschi T; Corradini R; Sforza S; Marchelli R; Capasso D; Saviano M; Pedone C
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12021-6. PubMed ID: 14512516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Watson-Crick interactions between PNA and DNA inhibit the ATPase activity of bacteriophage T4 Dda helicase.
    Tackett AJ; Corey DR; Raney KD
    Nucleic Acids Res; 2002 Feb; 30(4):950-7. PubMed ID: 11842106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PNA-nitrogen mustard conjugates are effective suppressors of HER-2/neu and biological tools for recognition of PNA/DNA interactions.
    Zhilina ZV; Ziemba AJ; Nielsen PE; Ebbinghaus SW
    Bioconjug Chem; 2006; 17(1):214-22. PubMed ID: 16417271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular properties and medical applications of peptide nucleic acids.
    Malcher J; Wesoły J; Bluyssen HA
    Mini Rev Med Chem; 2014 May; 14(5):401-10. PubMed ID: 24766383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and characterization of new chiral peptide nucleic acid (PNA) monomers.
    Falkiewicz B; Wisniowski W; Kolodziejczyk AS; Wisniewski K; Lankiewicz L
    Nucleic Acids Symp Ser; 1999; (42):29-30. PubMed ID: 10780363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The peptide nucleic acids (PNAs): introduction to a new class of probes for chromosomal investigation.
    Pellestor F; Paulasova P
    Chromosoma; 2004 Jun; 112(8):375-80. PubMed ID: 15156326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conjugates of PNA with naphthalene diimide derivatives having a broad range of DNA affinities.
    Mokhir AA; Kraemer R
    Bioconjug Chem; 2003; 14(5):877-83. PubMed ID: 13129390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity.
    Moggio L; Romanelli A; Gambari R; Bianchi N; Borgatti M; Fabbri E; Mancini I; di Blasio B; Pedone C; Messere A
    Biopolymers; 2007; 88(6):815-22. PubMed ID: 17918186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates.
    Kaihatsu K; Huffman KE; Corey DR
    Biochemistry; 2004 Nov; 43(45):14340-7. PubMed ID: 15533038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide nucleic acids as therapeutic agents.
    Nielsen PE
    Curr Opin Struct Biol; 1999 Jun; 9(3):353-7. PubMed ID: 10361091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General Recognition of U-G, U-A, and C-G Pairs by Double-Stranded RNA-Binding PNAs Incorporated with an Artificial Nucleobase.
    Ong AAL; Toh DK; Patil KM; Meng Z; Yuan Z; Krishna MS; Devi G; Haruehanroengra P; Lu Y; Xia K; Okamura K; Sheng J; Chen G
    Biochemistry; 2019 Mar; 58(10):1319-1331. PubMed ID: 30775913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression.
    Borgatti M; Finotti A; Romanelli A; Saviano M; Bianchi N; Lampronti I; Lambertini E; Penolazzi L; Nastruzzi C; Mischiati C; Piva R; Pedone C; Gambari R
    Curr Drug Targets; 2004 Nov; 5(8):735-44. PubMed ID: 15578953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extending recognition by peptide nucleic acids (PNAs): binding to duplex DNA and inhibition of transcription by tail-clamp PNA-peptide conjugates.
    Kaihatsu K; Shah RH; Zhao X; Corey DR
    Biochemistry; 2003 Dec; 42(47):13996-4003. PubMed ID: 14636068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular interactions with nuclear factor kappaB (NF-kappaB) transcription factors of a PNA-DNA chimera mimicking NF-kappaB binding sites.
    Romanelli A; Pedone C; Saviano M; Bianchi N; Borgatti M; Mischiati C; Gambari R
    Eur J Biochem; 2001 Dec; 268(23):6066-75. PubMed ID: 11733000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of peptide nucleic acid with modifications of its backbone and application in biotechnology.
    Das A; Pradhan B
    Chem Biol Drug Des; 2021 Apr; 97(4):865-892. PubMed ID: 33314595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The peptide nucleic acids (PNAs): a new generation of probes for genetic and cytogenetic analyses.
    Paulasova P; Pellestor F
    Ann Genet; 2004; 47(4):349-58. PubMed ID: 15581832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and determination of optical purity of γ-lysine modified peptide nucleic acid analogues.
    Huang H; Joe GH; Choi SR; Kim SN; Kim YT; Pak HS; Kim SK; Hong JH; Han HK; Kang JS; Lee W
    Arch Pharm Res; 2012 Mar; 35(3):517-22. PubMed ID: 22477199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide nucleic acids with a structurally biased backbone. Updated review and emerging challenges.
    Corradini R; Sforza S; Tedeschi T; Totsingan F; Manicardi A; Marchelli R
    Curr Top Med Chem; 2011; 11(12):1535-54. PubMed ID: 21510833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.